Biotech · Private company
Transgene
Track this companyFree. Adds Transgene to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- AvelumabPhase 2 · HPV-Related CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- ChemotherapyPhase 2 · Non Small Cell Lung Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Non Small Cell Lung Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- TG4001Phase 2 · HPV-Related CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TG4010Phase 2 · Non Small Cell Lung Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- TG4050Phase 2 · Squamous Cell Carcinoma of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- TG4050Phase 1 · Ovarian CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Clinical Trial Evaluating TG4050 in Head and Neck CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 12, 2019ClinicalTrials.gov NCT04183166 · fetched Nov 12, 2026
- A Trial Evaluating TG4050 in Ovarian Carcinoma.PHASE1 · COMPLETED · started Dec 9, 2019ClinicalTrials.gov NCT03839524 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)PHASE2 · COMPLETED · started Jan 5, 2018ClinicalTrials.gov NCT03353675 · fetched Nov 12, 2026
- Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M CancersPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 1, 2017ClinicalTrials.gov NCT03260023 · fetched Nov 12, 2026
- TG4010 and Nivolumab in Patients With Lung CancerPHASE2 · COMPLETED · started Dec 14, 2016ClinicalTrials.gov NCT02823990 · fetched Nov 12, 2026
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaPHASE1_PHASE2 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01394939 · fetched Nov 12, 2026